Bristol-Myers Squibb | BMY - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bristol-Myers Squibb

Bristol-Myers Squibb reported $1.76B in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
AbbVie ABBV:US USD 3B 217M
Abbott ABT:US USD 2.75B 83M
ALKERMES ALKS:US USD 174.48M 16.94M
Amgen AMGN:US USD 1.26B 210M
AstraZeneca AZN:LN USD 3.2B 331M
Biogen BIIB:US USD 605M 27.8M
Bristol-Myers Squibb BMY:US USD 1.76B 504M
Catalent CTLT:US USD 226M 30M
Coherus Biosciences CHRS:US USD 49.15M 4.47M
Drreddys Laboratories RDY:US INR 17.99B 1.43B
Eli Lilly LLY:US USD 1.75B 106M
Endo International ENDP:US USD 150.79M 26.16M
Gilead Sciences GILD:US USD 1.32B 702M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Horizon Pharma HZNP:US USD 453.35M 80.82M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
J&J JNJ:US USD 6.14B 374M
Merck & Co MRK:US USD 2.46B 209M
Novartis NOVN:VX USD 3.4B 298M
Perrigo PRGO:US USD 331.5M 25.9M
Pfizer PFE:US USD 3.49B 1.39B
Phibro Animal Health PAHC:US USD 56.99M 4.55M
Prestige Brands PBH:US USD 58.53M 1.58M
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Revance Therapeutics RVNC:US USD 63.87M 324K
Roche Holding ROG:VX CHF 6.48B 834M
United Therapeutics UTHR:US USD 87.3M 64.7M
Zoetis ZTS:US USD 505M 9M